Sharon S. Zhang

693 citations
7 papers · 568 indexed · h-index 6
Topics
Protein Tyrosine Phosphatases (3 papers)RNA modifications and cancer (2 papers)Metabolism, Diabetes, and Cancer (2 papers)
Partner nations
United StatesChinaItaly

In The Last Decade

Sharon S. Zhang

7 papers receiving 563 citations

Peers

Sharon S. Zhang
Comparison fields: 5 of 64
  • Molecular Biology 445
  • Immunology 183
  • Oncology 153
  • Cancer Research 99
  • Epidemiology 46
Replace Shuangwei Li with:
Shuangwei Li United States
Jan-Jacob Schuringa Netherlands
Wenjie Deng China
Ming Ma China
Anne L. Thaus Australia
Shuo Dong China
Karen M. Pomeranz United Kingdom
Takahiro Domoto Japan
Huai‐Xiang Hao United States
Sharon S. Zhang relative to Shuangwei Li United States Shuangwei Li's profile →
Citations per field
00.5×1.5×
Shuangwei Li · 1×
Citations per year

Countries citing papers authored by Sharon S. Zhang

Since Specialization
Citations

This map shows the geographic impact of Sharon S. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon S. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon S. Zhang more than expected).

Fields of papers citing papers by Sharon S. Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon S. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon S. Zhang. The network helps show where Sharon S. Zhang may publish in the future.

Co-authorship network of co-authors of Sharon S. Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon S. Zhang. A scholar is included among the top collaborators of Sharon S. Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon S. Zhang. Sharon S. Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 37
2 48
3 276
4
Regulation of Insulin Biosynthesis
2
5 37
6 109
7 59

About Sharon S. Zhang

Sharon S. Zhang is a scholar working on Endocrine and Autonomic Systems, Cancer Research and Hematology, having authored 7 papers that have together received 568 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (3 papers), RNA modifications and cancer (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Immunology (183 citations), Cancer Research (99 citations) and Molecular Biology (445 citations). Sharon S. Zhang has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Gen‐Sheng Feng, Helen He Zhu, Frédéric Princen, Shuangwei Li, Béatrice Bailly‐Maitre, Valeria Poli, Nissi Varki, Emilie A. Bard-Chapeau, Tao Han and Dong Fang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026